Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Ocean Biomedical's share price for the quarter that ended in Mar. 2025 was $0.054. Ocean Biomedical's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 166.01 Mil. Therefore, Ocean Biomedical's market cap for the quarter that ended in Mar. 2025 was $8.96 Mil.
Ocean Biomedical's quarterly market cap
declined
from Sep. 2024 ($34.17 Mil) to Dec. 2024 ($19.28 Mil) and
declined
from Dec. 2024 ($19.28 Mil) to Mar. 2025 ($8.96 Mil).
Ocean Biomedical's annual market cap
increased
from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($22.87 Mil) but then
declined
from Dec. 2023 ($22.87 Mil) to Dec. 2024 ($19.28 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ocean Biomedical's Enterprise Value for Today is $9.37 Mil.
Ocean Biomedical (OTCPK:OCEA) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ocean Biomedical Market Cap Related Terms
Ocean Biomedical Market Cap Historical Data
* Premium members only.
The historical data trend for Ocean Biomedical's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Ocean Biomedical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ocean Biomedical Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Ocean Biomedical's Market Cap distribution charts can be found below:
* The bar in red indicates where Ocean Biomedical's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Ocean Biomedical's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocean Biomedical (OCEA) has a Market Cap of $0.02 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ocean Biomedical and its competitors.
Is Ocean Biomedical's Market Cap too high?
Ocean Biomedical's current Market Cap is $0.02 Mil. The Biotechnology industry median Market Cap is 114.03. Ocean Biomedical's value of $0.02 Mil is 100% below this industry median.
How does Ocean Biomedical's Market Cap compare to SIGY and ENDV?
Ocean Biomedical's Market Cap of $0.02 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 114.03. Ocean Biomedical's value of $0.02 Mil is 100% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.03, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ocean Biomedical's current Market Cap of $0.02 Mil is 100% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ocean Biomedical and its competitors. For the Biotechnology industry, the median Market Cap is 114.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ocean Biomedical's current Market Cap is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocean Biomedical stock overvalued right now?
Ocean Biomedical (OCEA) has a current Market Cap of $0.02 Mil. The current Market Cap is $0.02 Mil and 100% below the Biotechnology industry median of 114.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ocean Biomedical (OCEA), the current Market Cap is $0.02 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCEA has been successfully added to your 